ArticleBiology direct2026
Single-cell RNA sequencing reveals lipid metabolism disorders in the retina in spontaneous high myopia.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundMyopia is one of the most common eye diseases affecting children and adolescents, with its etiology often attributed to a combination of genetic and environmental factors. This study utilized single-cell RNA sequencing (scRNA-seq) technology to investigate gene expression differences between guinea pigs with spontaneous high myopia (SHM) and those with normal vision.
resultsLens-induced myopia (LIM) and SHM guinea pigs exhibit significant retinal structural abnormalities and functional impairments, characterized by reduced retinal thickness and abnormal electroretinogram (ERG) responses, indicating progressive retinal dysfunction during myopia development. scRNA-seq and molecular experiments revealed that the ceramide synthase 5 (CERS5) / ceramide synthase 6 (CERS6) / alkaline ceramidase 3 (ACER3) / phospholipid phosphatase 1 (PLPP1) / prosaposin (PSAP) / UDP-glucose ceramide glucosyltransferase (UGCG) signaling axis is significantly activated in the retinas of myopic guinea pigs, suggesting dysregulation of sphingolipid metabolism. These changes were associated with an increased expression of SPHK1 and a shift in receptor expression from S1PR1 to S1PR2, indicating a transition in lipid signaling from a physiological state to a stress-related pathological state. Additionally, the activation of the P62/NRF2/KEAP1 pathway confirmed enhanced oxidative stress in the myopic retina. This study demonstrates that the CERS5/CERS6/ACER3/PLPP1/PSAP/UGCG signaling axis mediates disruption of sphingolipid metabolism and oxidative stress in the myopic guinea pig retina.
conclusionsThe present study demonstrates that the CERS5/CERS6/ACER3/PLPP1/PSAP/UGCG signaling axis mediates sphingolipid metabolic dysregulation and oxidative stress in the retinas of myopic guinea pigs. Mechanistically, the abnormal activation of the SPHK1-S1P signaling pathway, the shift in receptors from S1PR1 to S1PR2, and the subsequent activation of the P62/KEAP1/NRF2 pathway collectively led to changes in retinal morphology (such as reduced thickness) and functional impairment. These findings establish a mechanistic link between lipid metabolic imbalance and retinal pathology in myopia offering potential therapeutic targets for preventing retinal damage associated with myopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.